medicines" [4] through biomarker-driven clinical development, but it is far from clear whether approaches relevant to other therapeutic settings (e.g. hypertension) will apply to cancer drug ...

The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo ...

Skin surface biomarkers are increasingly recognised as essential measuring tools in dermatological science for non-invasive ...

Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

dramatically speeding up biomarker research and enhancing the pace of personalized medicine development. By automating repetitive tasks such as sample preparation, liquid chromatography (LC) ...

Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

The 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe, held in London from April 8th to 10th, aims to address common concerns among European Biomarker, Translational, and Clinical ...